BPC-157
Body Protection Compound-157 • Also called BPC 157, Body Protection Compound 157
BPC-157 is a synthetic peptide associated with tissue repair and gut-healing claims, but it remains one of the most watched restricted peptides in U.S. compounding.
Current status
Restricted
Recovery and GI-related interest, with current federal compounding constraints still in play.
FDA category
Category 2
Can pharmacies compound this?
No
Reclassification expected?
Yes
Market watchers continue to treat BPC-157 as a leading candidate for future FDA reconsideration, but no formal change has landed.
Primary Use
Recovery and GI-related interest
Also searched as
BPC 157, Body Protection Compound 157
Regulatory Timeline
Feb 27, 2026
Political pressure and market expectations increased around a future peptide reclassification review.
Sep 29, 2023
Current status signal recorded: Placed on FDA Category 2 lists for compounding restrictions..
Mar 15, 2023
FDA peptide compounding scrutiny intensified across 503A and 503B channels.
Get notified...
Get notified when BPC-157 status changes
State-specific notes
California
Dispensing posture is especially conservative.
Texas
Compounding partners typically avoid it entirely.